H. Veelken et al., DRUG-RESISTANCE OF SECONDARY ACUTE MYELOID-LEUKEMIA WITH MEGAKARYOBLASTIC FEATURES AND P190 BCR-ABL REARRANGEMENT, Leukemia research, 22(11), 1998, pp. 1021-1027
A 46-year-old female presented with acute myeloid leukemia during comp
lete remission of multiple myeloma after extensive treatment with alky
lating agents. Leukemic blasts expressed CD34, platelet esterase and g
p IIIa. RT-PCR analyses of peripheral blood cells detected a p190 type
BCR-ABL rearrangement and high levels of MDR1. The patient expired du
ring neutropenia shortly after induction chemotherapy. Autopsy reveale
d persistent blasts in the bone marrow, spleen and liver. 'Secondary'
acute myeloid leukemia with megakaryoblastic features and p190-type BC
R-ABL rearrangement has not previously been reported. The possibility
that the combination of a BCR-ABL rearrangement with overexpression of
MDR1 may have contributed to the treatment-refractory course is discu
ssed. (C) 1998 Elsevier Science Ltd. All rights reserved.